To test whether prophylactic administration of uPAR CAR T cells could impede the development of metabolic disorders in young mice given an HFD, we administered 0.5 × 106 m.uPAR-m.28z CAR T cells 1.5 months before placement on an HFD (Fig. 7j). The gene discussed is PLAUR; the disease is metabolic disease.